Search results for: 'signet cancer partnering 221b 2004'
- Did you mean
- signet cancer partnering 2016 2025
- Related search terms
- partnering agreements with bodi 2020 2016
- partnering agreements with regeneron pharmaceutical 2020 2025
- partnering agreements with cephalon 2020 2025
- partnering agreements with csl 2025 2020
- partnering agreements where actavis formerly watson pharmaceutical 2025 2025
-
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2026) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Animal Health Partnering Terms and Agreements 2017 to 2026March 2026$3,995.00Provides comprehensive understanding and unprecedented access to the animal health agreements entered into by the world's leading biopharma companies.
Learn More -
Oncology Collaboration and Licensing Deals 2020-2026April 2026$4,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2026
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2026March 2026$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026March 2026$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More -
Metagenomics Market: Global Market Analysis with Forecasts by Application, Technology, Product and User with Executive and Consultant Guides 2025 to 2029January 2025$6,995.00Metagenomics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2026March 2026$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More
